The associations of oxidized high-density lipoprotein lipids with risk factors for atherosclerosis: The Cardiovascular Risk in Young Finns Study

Free Radical Biology and Medicine

Volumn 65, Issue , 2013, Pages 1284-1290

  Kresanov, Petri ^a   Ahotupa, Markku ^b   Vasankari, Tommi ^c   Kaikkonen, Jari ^a   Kähönen, Mika ^d   Lehtimäki, Terho ^e   Viikari, Jorma ^b   Raitakari, Olli T ^a,f  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Atherosclerosis; Free radicals; HDL; LDL; Oxidized lipids; Risk factors for atherosclerosis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; INSULIN; OXIDIZED HIGH DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; WAIST CIRCUMFERENCE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CVD; FREE RADICALS; HDL; LDL; OXHDLLIPIDS; OXIDIZED HIGH-DENSITY LIPOPROTEIN LIPIDS; OXIDIZED LIPIDS; OXIDIZED LOW-DENSITY LIPOPROTEIN LIPIDS; OXIDIZED LOW-DENSITY LIPOPROTEIN PROTEIN; OXLDLLIPIDS; OXLDLPROT; RISK FACTORS FOR ATHEROSCLEROSIS;

ADULT; AGING; ALCOHOL DRINKING; APOLIPOPROTEINS B; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMANS; INSULIN; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; OXIDATION-REDUCTION; RISK FACTORS; SMOKING; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84886714357     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.09.023     Document Type: Article

References (27)

1. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, and T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study Am. J. Med. 62 1977 707 714
2. M. Briel, I. Ferreira-Gonzalez, J.J. You, P.J. Karanicolas, E.A. Akl, and P. Wu Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis BMJ 338 2009 b92
3. A.V. Khera, M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M.F. Burke, K. Jafri, B.C. French, J.A. Phillips, M.L. Mucksavage, R.L. Wilensky, E.R. Mohler, G.H. Rothblat, and D.J. Rader Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N. Engl. J. Med. 364 2011 127 135
4. M. Navab, S.T. Reddy, B.J. Van Lenten, and A.M. Fogelman HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms Nat. Rev. Cardiol 8 2011 222 232
5. C. Baigent, A. Keech, P.M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, and R. Simes Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
6. F. Spillmann, H.P. Schultheiss, C. Tschope, and S. Van Linthout High-density lipoprotein-raising strategies: update 2010 Curr. Pharm. Des. 16 2010 1517 1530
7. P.J. Barter, M. Caulfield, M. Eriksson, S.M. Grundy, J.J. Kastelein, M. Komajda, J. Lopez-Sendon, L. Mosca, J.C. Tardif, D.D. Waters, C.L. Shear, J.H. Revkin, K.A. Buhr, M.R. Fisher, A.R. Tall, and B. Brewer ILLUMINATE Investigators. Effects of torcetrapib in patients at high risk for coronary events N. Engl. J. Med. 357 2007 2109 2122
8. B.F. Voight, G.M. Peloso, M. Orho-Melander, R. Frikke-Schmidt, M. Barbalic, and M.K. Jensen Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study Lancet 380 2012 572 580
9. B.F. Asztalos, M. Tani, and E.J. Schaefer Metabolic and functional relevance of HDL subspecies Curr. Opin. Lipidol. 22 2011 176 185
10. M. Ahotupa, J.P. Suomela, T. Vuorimaa, and T. Vasankari Lipoprotein-specific transport of circulating lipid peroxides Ann. Med. 42 2010 521 529
11. J.L. Witztum The oxidation hypothesis of atherosclerosis Lancet 344 1994 793 795
12. J.A. Berliner, and A.D. Watson A role for oxidized phospholipids in atherosclerosis N. Engl. J. Med. 353 2005 9 11
13. O.T. Raitakari, M. Juonala, T. Rönnemaa, L. Keltikangas- Järvinen, L. Räsänen, M. Pietikäinen, N. Hutri-Kähönen, L. Taittonen, E. Jokinen, J. Marniemi, A. Jula, R. Telama, M. Kähönen, T. Lehtimäki, H.K. Åkerblom, and J.S. Viikari Cohort profile: the Cardiovascular Risk in Young Finns Study Int. J. Epidemiol. 37 2008 1220 1226
14. M. Ahotupa, J. Marniemi, T. Lehtimäki, K. Talvinen, O.T. Raitakari, T. Vasankari, J. Viikari, J. Luoma, and S. Ylä-Herttuala Baseline diene conjugation in LDL lipids as a direct measure of in vivo LDL oxidation Clin. Biochem. 31 1998 257 261
15. S. Väisänen, J. Gavert, A. Julkunen, E. Voutilainen, and I. Penttilä Contents of apolipoprotein A-I, A-II and B of the human serum fractions for high-density and low-density lipoproteins prepared by common precipitation methods Scand. J. Clin. Lab. Invest 52 1992 853 862
16. P. Holvoet, E. Macy, M. Landeloos, D. Jones, N.S. Jenny, F. Van de Werf, and R.P. Tracy Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL Clin. Chem. 52 2006 760 764
17. J.K. Christison, K.A. Rye, and R. Stocker Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein J. Lipid Res. 36 1995 2017 2026
18. J. Christison, A. Karjalainen, J. Brauman, F. Bygrave, and R. Stocker Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ Biochem. J. 314 1996 739 742
19. K. Fluiter, H. Vietsch, E.A. Biessen, G.M. Kostner, T.J. van Berkel, and W. Sattler Increased selective uptake in vivo and in vitro of oxidized cholesteryl esters from high-density lipoprotein by rat liver parenchymal cells Biochem. J. 319 1996 471 476
20. B. Shao, and J.W. Heinecke HDL, lipid peroxidation, and atherosclerosis J. Lipid Res. 50 2009 599 601
21. K. Juul, L.B. Nielsen, K. Munkholm, S. Stender, and B.G. Nordestgaard Oxidation of plasma low-density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo Circulation 94 1996 1698 1704
22. W. Sattler, and R. Stocker Greater selective uptake by Hep G2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters Biochem. J 294 1993 771 778
23. J.O. Toikka, H. Laine, M. Ahotupa, A. Haapanen, J.S. Viikari, J.J. Hartiala, and O.T. Raitakari Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension Hypertension 36 2000 929 933
24. T. Vasankari, M. Lehtonen-Veromaa, T. Möttönen, M. Ahotupa, K. Irjala, O. Heinonen, A. Leino, and J. Viikari Reduced mildly oxidized LDL in young female athletes Atherosclerosis 151 2000 399 405
25. M. Ahotupa, M. Ruutu, and E. Mäntylä Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins Clin. Biochem. 29 1996 139 144
26. A.S. Kelly, D.R. Jacobs Jr, A.R. Sinaiko, A. Moran, L.M. Steffen, and J. Steinberger Relation of circulating oxidized LDL to obesity and insulin resistance in children Pediatr. Diabetes 11 2010 552 555
27. M.T. Cooney, A. Dudina, D. De Bacquer, L. Wilhelmsen, S. Sans, A. Menotti, G. De Backer, P. Jousilahti, U. Keil, T. Thomsen, P. Whincup, and I.M. Graham SCORE Investigators. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk Atherosclerosis 206 2009 611 616